These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Bone mineral content in epileptics. Lidgren L; Nilsson BE; Wallöe A Calcif Tissue Int; 1979 Oct; 28(2):99-102. PubMed ID: 116733 [TBL] [Abstract][Full Text] [Related]
7. Bone status after long-term anticonvulsant therapy in epileptic patients: evaluation using quantitative ultrasound of calcaneus and phalanges. Pluskiewicz W; Nowakowska J Ultrasound Med Biol; 1997; 23(4):553-8. PubMed ID: 9232764 [TBL] [Abstract][Full Text] [Related]
8. Incidence of anticonvulsant osteomalacia and effect of vitamin D: controlled therapeutic trial. Christiansen C; Rodbro P; Lund M Br Med J; 1973 Dec; 4(5894):695-701. PubMed ID: 4776883 [TBL] [Abstract][Full Text] [Related]
9. Latent osteomalacia in epileptic patients on anticonvulsants. Christiansen C; Kristensen M; Rodbro P Br Med J; 1972 Sep; 3(5829):738-9. PubMed ID: 5077915 [TBL] [Abstract][Full Text] [Related]
10. Anticonvulsant osteomalacia determined by quantitative analysis of bone changes. Population study and possible risk factors. Mosekilde L; Melsen F Acta Med Scand; 1976; 199(5):349-55. PubMed ID: 1274672 [TBL] [Abstract][Full Text] [Related]
12. Biochemical variables related to calcium metabolism in epileptics. Dymling JF; Lidgren L; Wallöe A Acta Med Scand; 1979; 205(5):401-4. PubMed ID: 443079 [TBL] [Abstract][Full Text] [Related]
13. Does carbamazepine cause disturbances in calcium metabolism in epileptic patients? Tjellesen L; Nilas L; Christiansen C Acta Neurol Scand; 1983 Jul; 68(1):13-9. PubMed ID: 6613523 [TBL] [Abstract][Full Text] [Related]
14. Response to Zhou et al. Osteomalacia is a frequent complication resulting from long-term therapy with drugs such as phenytoin, carbamazepine, and phenobarbital. Pascussi JM; Maurel P; Vilarem MJ J Clin Invest; 2006 Oct; 116(10):2564. PubMed ID: 17016548 [No Abstract] [Full Text] [Related]
15. Quantitative in-vivo determination of bone mineral using computerized roentgenographic densitometry. Price RI; Retallack RW; Gutteridge DH; Black JL; Glancy J; Hughes D; Munslow-Davies L; Uitermark E; Mallal SA Australas Phys Eng Sci Med; 1983; 6(3):128-37. PubMed ID: 6679276 [No Abstract] [Full Text] [Related]
16. Anticonvulsant-induced dyskinesias: a comparison with dyskinesias induced by neuroleptics. Chadwick D; Reynolds EH; Marsden CD J Neurol Neurosurg Psychiatry; 1976 Dec; 39(12):1210-8. PubMed ID: 1011032 [TBL] [Abstract][Full Text] [Related]
17. Long-term anticonvulsant therapy leads to low bone mineral density--evidence for direct drug effects of phenytoin and carbamazepine on human osteoblast-like cells. Feldkamp J; Becker A; Witte OW; Scharff D; Scherbaum WA Exp Clin Endocrinol Diabetes; 2000; 108(1):37-43. PubMed ID: 10768830 [TBL] [Abstract][Full Text] [Related]
18. Effects of anticonvulsant drug therapy on bone mineral density in a pediatric population. Timperlake RW; Cook SD; Thomas KA; Harding AF; Bennett JT; Haller JS; Anderson RM J Pediatr Orthop; 1988; 8(4):467-70. PubMed ID: 3392200 [TBL] [Abstract][Full Text] [Related]
19. Osteomalacic myopathy: an uncommon side effect of antiepileptic drugs. Assenza G; Campana C; Tombini M; Cosimo Quattrocchi C; Giambattistelli F; Benvenga A; Pellegrino G; Assenza F; Vernieri F; Di Lazzaro V Muscle Nerve; 2013 Nov; 48(5):837-8. PubMed ID: 23761293 [No Abstract] [Full Text] [Related]
20. [Evaluation of anticonvulsant-induced bone changes by a microdensitometric method]. Iwata Y; Amano K; Kawamura H; Tanikawa T; Kawabatake H; Notani M; Iseki H; Shiwaku T; Nagao T; Taira T No Shinkei Geka; 1985 Mar; 13(3):293-9. PubMed ID: 4010879 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]